Earnings Release 1Q18. May 11 th, 2018

Similar documents
Earnings Release 2Q18. August 15 th, 2018

Earnings Release 4Q17. March 16 th, 2018

Consolidated Income Statement - (R$ MM) Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Qualicorp Consultoria e Corretora de Seguros S.A.

Qualicorp Consultoria e Corretora de Seguros S.A.

Consolidated Income Statement - (R$ MM) 1Q16 1Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Consolidated Income Statement - (R$ MM) 2Q16 2Q15. Balance Sheet 1Q Equity 2, , % Net Debt¹ % O ther 1Q

Consolidated Income Statement - Balance Sheet 1Q Equity 2, , % Net Debt¹ % Other 1Q

Qualicorp Consultoria e Corretora de

Income Statement (Ex -CRC/Gam a) - Balance Sheet Equity¹ 1.993, ,8-15,4% Net Debt² 497,3 227,3 118,8% Other

Consolidated Income Statement - (R$ MM) Balance Sheet Equity 2, , % Net Debt¹

QUALICORP REPORTS 2Q11 GROWTH IN THE NUMBER OF BENEFICIARIES (18.5%), NET REVENUEs (43.9%) AND ADJUSTED EBITDA (36.6%) AS COMPARED TO 2Q10 1

3Q12 Earnings Release

Contacts

Highlights 3Q13. Affinity Health Net adds. Affinity Health Portfolio. % change 3Q13/4Q12

São Paulo, May 14th, 2018 SOMOS Educação S.A. (B3: SEDU3)

NMG Investment Case 3Q17 Update June 14, 2017

2Q15 Results FLRY3. July 2015

Q Earnings Key Metrics

Q Earnings Key Metrics

3Q16 Results Presentation. November 04, 2016

2016 and 4Q16 Results FLRY3. March 2017

Reconciliation of Non-GAAP Metrics and Definitions

3Q17 EARNINGS RESULTS

2017 SECOND QUARTER RESULTS. Ended June 30, 2017

SOMOS Educação ER 3Q17

Earnings Conference Call 3Q17. October 26 th, 2017

2017 FIRST QUARTER RESULTS. Ended March 31, 2017

4Q17 and 2017 Earnings Release Resultados 4T12

Conference Call 4Q11 Results. March 09, 2012

1H / 2005 Results Data Conference. September 1 st, 2005

Tempo Assist announces year-on-year Net Revenue and Net Income growth of 24.7% and 90.0%, respectively, in 1Q11

Alternative Performance Measures 2017

Strong Operating Cash Generation: R$ 263 MM Net Debt reduced to 1.06x EBITDA LTM Growth of 15.7% in Bookings and 21.1% in Profit. Period Highlights*

First Quarter 2004 Financial Results

FIRST QUARTER OF 2018 RESULTS

2017 THIRD QUARTER RESULTS. Ended September 30, 2017

Non-Deal Roadshow Presentation

financial report 1Q14 Management Discussion & Analysis and Complete Financial Statements

2Q10 Results. August, 2010 FLRY3

SOMOS Educação ER 4Q17

THIRD QUARTER OF 2018 RESULTS HIGHLIGHTS. Net revenues grew 20.5% over 3T17. RECENT EVENTS

RESULTS 2Q16. Investor Relations Telefônica Brasil S.A. July, 2016

Earnings Conference Call OPÇÕES 1Q16

Earnings Supplement 2 nd Quarter August 5, 2016

Q Earnings Key Metrics

Celulose Irani S.A. Quarterly Information (ITR) at September 30, 2015 and report on review of quarterly information

2016 Amadeus IT Group SA Results. February 26, 2016

Consolidated Net Revenue from Products

3Q16 results FLRY3. October 2016

Investor Presentation

CVS Health Corporation Supplemental Financial Information Preliminary and Unaudited. Fourth Quarter 2014 Earnings Release February 10, 2015

1Q18 Results May 10, 2018

3Q18 EARNINGS. Food Business Multivarejo Assaí. (R$ million) (1) 3Q18 3Q17 Δ 3Q18 3Q17 Δ 3Q18 3Q17 Δ 3Q18 3Q17 Δ

Highlights of the third quarter of 2017

4Q18 & 2018 EARNINGS RELEASE

management discussion analysis Itaú Unibanco Holding S.A.

financial report September 30, 2013

4Q17 Earnings Presentation

Results Presentation Q1 2017

Q2 FY19 Supplemental Earnings Slides. October 29, 2018

Press release August 30, FIRST-HALF 2017 RESULTS Solid sales growth of +6.2% Recurring operating income of 621m

5. Income statement items and other comprehensive income

Companhia Brasileira de Distribuição

Q Earnings Release Published October 29, 2018 (Earnings Conference Call October 30, 2018)

1Q18 Earnings Presentation

5. Income statement items

CONSOLIDATED FINANCIAL STATEMENTS

Results 3Q18. Investor Relations Telefônica Brasil S.A. October, 2018

Investor Presentation. Domino s Pizza

Orange Polska 4Q 17 and FY 17 results. 21 February 2018

Earnings Conference Call 1Q14

CONSOLIDATED FINANCIAL STATEMENTS

Valid reports Net Revenue of R$412.1 million in 3Q17, down 3.2% from 3Q16 and up 5.2% from 2Q17.

2009 Earnings Release

EARNINGS RELEASE 1Q18 RESULTADOS

Q Earnings Release Published February 25, 2019 (Earnings Conference Call February 26, 2019)

Tenth Annual Chile Conference Santander GLOBAL BANKING & MARKETS

Q Earnings Key Metrics

Cash Interest. Adjusted EBITDA Reconciliations

Q (Ended June 30, 2018) Conference Call. August 10, 2018

Cremer S.A. On September 30 th, 2018

Fleury S.A. Quarterly Information (ITR) at September 30, 2015 and Report on Review of Quarterly Information

Financial Year 1H19 Results

Results 3Q18. October 25, 2018 B3: LREN3; USOTC:LRENY. CONFERENCE CALL ON RESULTS October :00 p.m. (Brazil) / 12 noon (US-EST)

Financial and Economic Performance 2015

4Q16 Results March 17, 2017

2Q17 Results Presentation. August 10 th, 2017

(A free translation of the original in Portuguese)

4Q17 Results. CONFERENCE CALL ON RESULTS February 09, :00 p.m. (Brazil) / 10:00 a.m. (US-EST)

2015 and 4Q15 Results FLRY3. March 2016

Siemens Gamesa Renewable Energy Q Results

3Q18 Earnings November 8, 2018

3Q16 EARNINGS RELEASE. Viver Announces its Results for the Third Quarter of Highlights

Q SALES AND RESULTS

First Quarter 2019 Earnings Presentation February 6, 2019

TELECOM ARGENTINA S.A.

2Q17 RESULTS. Operating Highlights. Financial Highlights. Outlook

Q1 FY17 FINANCIAL RESULTS CONFERENCE CALL November 7, 2016 at 5:00 pm ET

HMS Group 3 months 2018 IFRS Results Webcast presentation. 8 June 2018

Transcription:

Earnings Release 1Q18 May 11 th, 2018

Legal Warning Forward-looking statements This release may contain forward-looking statements concerning the business outlook, estimates of operating and financial results and growth prospects of Qualicorp S.A. These statements are based exclusively on the expectations of the management of Qualicorp S.A. regarding the prospects of the business and its continued ability to access capital markets to finance its business plan. These forwardlooking statements are highly sensitive to changes in the capital markets, government regulations, competitive pressures, the performance of the industry and the Brazilian economy and other factors, as well as to the risk factors highlighted in documents previously filed by Qualicorp S.A., and therefore are subject to change without prior notice. 2

Main Indicators Consolidated Income Statement - (R$ MM) 1Q18 1Q17 1Q18/ Net Revenues 479.2 481.4-0.5% 483.3-0.9% Total Expenses (Ex-Depreciation and amortizatio (230.9) (250.5) -7.8% (270.7) -14.7% Adjustments to EBITDA (11.7) 5.0-335.4% (11.4) 3.1% Adjusted EBITDA 236.6 235.8 0.3% 201.2 17.6% Adjusted EBITDA Margin 49.4% 49.0% 39bps 41.6% 774bps Net Income (Loss) 102.7 111.0-7.5% 91.1 12.7% Balance Sheet 1Q18 2017 Change 1Q17/2017 Equity 2,281.9 2,415.4-5.5% Net Debt¹ 132.8 134.8-1.4% O ther 1Q18 2017 Change 1Q17/2017 Net Debt / Equity 0.06x 0.06x 4.3% Net Debt / Adjusted EBITDA LTM 0.14x 0.16x -9.2% (¹) Includes acquisition payables recognized as other payables. It does not include the investment retained as a guaranteed asset in the direct subsidiary Qualicorp Administradora de Benefícios S.A. and Clube de Saúde Administradora de Benefícios Ltda., according to the 33rd normative instruction by the ANS, from October 5, 2009. 3

Portfolio Evolution (cont.) (cont.) Portfolio 1Q18 1Q17 1Q18/ Affinity Health Lives Total Portfolio (BOP) 1,211,591 1,369,676-11.5% 1,276,883-5.1% (+) Gross Adds 97,805 84,629 15.6% 82,636 18.4% (-) Churn (97,602) (104,675) -6.8% (147,928) -34.0% (+) Portfolio Acquisition 10,912 - N.A. - N.A. New Lives Added (net) 11,115 (20,046) -155.4% (65,292) -117.0% Total Portfolio (EOP) 1,222,706 1,349,630-9.4% 1,211,591 0.9% Affinity Other Products Lives Total Portfolio (BOP) 346,635 421,321-17.7% 386,469-10.3% New Lives Added (net) (225,028) (14,424) 1460.1% (39,834) 464.9% Total Portfolio (EOP) 121,607 406,897-70.1% 346,635-64.9% Affinity Portfolio 1,344,313 1,756,527-23.5% 1,558,226-13.7% Corporate 768,513 494,538 55.4% 717,929 7.0% TPA 793,695 2,235,055-64.5% 2,212,008-64.1% Small/Medium Enterprises 146,680 27,261 438.1% 28,916 407.3% Health Management - 4,322 N.A. - N.A. Corporate and Others Portfolio 1,708,888 2,761,176-38.1% 2,958,853-42.2% Total Portfolio 3,053,201 4,517,703-32.4% 4,517,079-32.4% 4

Net Revenues Net Revenues (R$ MM) 1Q18 1Q17 1Q18/ Affinity 440.4 438.9 0.4% 441.4-0.2% % on Total Net Revenues 91.9% 91.2% 75bps 91.3% 58bps Corporate and Other 38.8 42.5-8.9% 41.9-7.5% % on Total Net Revenues 8.1% 8.8% -75bps 8.7% -58bps Total Consolidated 479. 2 481. 4-0. 5% 483. 3-0. 9% NET REVENUES (R$ MM) - 0.5% - 0.9% 481.4 479.2 483.3 479.2 1Q17 1Q18 1Q18 5

Cost of Services Cost of Services (R$ MM) 1Q18 1Q17 a) Refers to expenses from financial pass through incurred in connection with the agreements signed with professional associations for the contracting and selling of affinity plans (called royalties). b) Refers primarily to mailing expenses and annual membership fees paid by the Company to associations, unions and councils on behalf of the beneficiaries / members of the professional associations. GROSS MARGIN 1Q18/ Personnel expenses (30.3) (41.7) -27.3% (36.8) -17.6% Third Party Services (24.8) (22.7) 9.4% (15.9) 56.0% Occupancy expenses (4.0) (2.9) 36.6% (2.2) 80.5% Royalties (a) (24.2) (24.8) -2.5% (26.6) -9.1% Others (b) (8.7) (9.0) -3.7% (13.6) -35.8% Total Consolidated (92.0) (101.1) -9.0% (95.0) -3.2% Gross Margin 80.8% 79.0% 181bps 80.3% 47bps 450 85% 79.0% 80.0% 80.5% 80.3% 80.8% 80% 419.3 75% 70% 400 390.1 388.3 387.2 65% 380.3 60% 55% 350 1Q17 2Q17 3Q17 1Q18 Gross Profit Gross Margin 50% 6

Administrative Expenses Administrative expenses (R$ MM) 1Q18 1Q17 1Q18/ Personnel expenses (22.7) (29.9) -24.4% (24.0) -5.5% Third Party services (11.7) (18.9) -38.0% (26.0) -54.9% Occupancy expenses (2.6) (4.1) -35.6% (3.9) -31.8% Depreciation and amortization (60.1) (58.2) 3.3% (55.4) 8.6% Others (15.7) (10.5) 49.2% (34.5) -54.5% Total Consolidated (112.8) (121.6) -7.3% (143.6) -21.5% (+) Stock Options Expenses 0.3 7.1-95.5% 1.4-77.4% Total Recurring Adm. Expenses (112.5) (114.5) -1.8% (142.2) -20.9% Recurring Adm. Expenses/ Net Revenue % 23.5% 23.8% -32bps 29.4% -595bps ADMINISTRATIVE EXPENSES (% REVENUES) 200.00 29.4% 30.0% 180.00 160.00 23.8% 23.3% 24.1% 23.5% 25.0% 140.00 120.00 114.5 113.7 125.7 142.2 112.5 20.0% 100.00 15.0% 80.00 60.00 10.0% 40.00 5.0% 20.00 0.00 1Q17 2Q17 3Q17 1Q18 Adm. Expenses (Ex. SOP) % Revenue 0.0% 7

Selling Expenses Selling Expenses (R$ MM) 1Q18 1Q17 (a) Considers office supplies, mailing and discounts. 1Q18/ Personnel expenses (13.7) (12.9) 6.2% (11.8) 16.4% Third Party services (3.9) (3.0) 29.8% (2.9) 37.6% Occupancy expenses (1.9) (1.7) 11.8% (1.5) 22.5% Sales campaign (4.8) (9.6) -49.8% (5.3) -8.8% Sponsorships (1.4) (1.6) -11.7% (2.6) -44.4% New sales comission amortization (18.1) (17.4) 3.8% (18.8) -3.5% Third-party commission (14.5) (18.6) -22.3% (14.5) 0.1% Publicity and advertising (4.7) (4.2) 13.4% (6.5) -27.3% Others (a) (2.0) (2.6) -20.1% (3.7) -44.1% Total Consolidated (65.1) (71.6) -9.1% (67.4) -3.4% Selling/Net Revenue % 13.6% 14.9% -129bps 13.9% -36bps 100.0 SELLING EXPENSES (% REVENUES) 20.0% 18.0% 14.9% 15.9% 13.9% 13.9% 13.6% 16.0% 14.0% 77.5 12.0% 75.0 71.6 72.1 10.0% 67.4 65.1 8.0% 6.0% 4.0% 2.0% 50.0 1Q17 2Q17 3Q17 1Q18 Selling Expenses % Revenue 0.0% 8

Bad Debt (Uncollectible Receivables) and Other Operating Income (Expense) Bad Debt (R$ MM) 1Q18 1Q17 1Q18/ Bad Debt/Uncollectible Receivables (34.9) (28.5) 22.4% (40.1) -13.1% % Net Revenue 7.3% 5.9% 136bps 8.3% -103bps Breakdown 1Q18 1Q17 1Q18/ Bad Debt (40.2) (32.7) 23.0% (43.5) -7.6% Recovering 5.3 4.2 27.5% 3.3 59.0% Other Operating 1Q18 1Q17 Income/Expenses (R$ MM) 1Q18/ Expenses related to contingencies (5.9) (3.9) 50.1% (2.3) 160.8% Impairment 0.7 0.6 26.1% 0.0 3398.9% Operational Losses 5.8 (0.2) -2581.8% 6.5-10.7% Other income (expenses) (5.0) 0.3-1738.9% (2.9) 72.3% Total Consolidated (4.3) (3.3) 31.2% 1.4-407.4% 9

Financial Income (Expense)) Financial Income (Expenses) (R$MM) 1Q18 1Q17 1Q18/ Financial income Income from short-term investments 9.2 17.7-48.4% 11.8-22.6% Interest and fine on late payment of health plans 6.1 15.3-60.3% 7.6-19.6% Other income 1.1 6.3-81.9% 1.0 9.1% Total 16.4 39.4-58.4% 20.4-19.9% Financial expenses Debentures Interest (11.8) (21.0) -43.9% (12.9) -8.4% Monetary adjustment from acquisition payables (0.2) (8.5) -97.6% (1.3) -84.7% Other financial expenses (10.6) (11.1) -4.8% (11.8) -10.6% Total (22.6) (40.6) -44.5% (26.0) -13.3% Total Consolidated (6.2) (1.2) 395.2% (5.6) 10.8% 10

Adjusted EBITDA EBITDA and Adjusted EBITDA (R$ MM) 1Q18 1Q17 1Q18/ Net Income 102.7 111.0-7.5% 91.1 12.7% (+) Taxes 61.2 43.0 42.3% 43.1 42.1% (+) Depreciation and Amortization 78.2 75.6 3.4% 74.1 5.5% (+) Financial Expense 22.6 40.6-44.5% 25.9-12.8% (-) Financial Income (16.4) (39.4) -58.4% (21.6) -24.1% EBITDA 248.3 230.9 7.6% 212.6 16.8% EBITDA Margin 51.8% 48.0% 386bps 44.0% 783bps Non-cash Stock Option Plan Expense 0.3 7.1-95.5% 1.4-77.4% Interest and fine on late payment of health plans 6.1 15.3-60.3% 6.0 1.2% New sales comission amortization (18.1) (17.4) 3.8% (18.8) -3.5% Adjusted EBITDA 236.6 235.8 0.3% 201.2 17.6% Adjusted EBITDA Margin 49.4% 49.0% 39bps 41.6% 774bps 350 300 250 49.0% 48.7% 235.8 237.6 50.6% 263.5 41.6% 201.2 49.4% 236.6 50.0% 40.0% 200 30.0% 150 20.0% 100 50 10.0% 0 1Q17 2Q17 3Q17 1Q18 0.0% Adjusted EBITDA EBITDA Margin 11

Net Income (Loss) Net Income (Loss) (R$ MM) 1Q18 1Q17 1Q18/1Q1 1Q18/ Net Income 102.7 110.5-7.0% 89.4 14.9% NET INCOME (LOSS) R$ - 7.04% 110.5 102.7 + 14.9% 102.7 89.4 1Q17 1Q18 1Q18 12

Investments¹ (CAPEX) and Capital Structure Capex (R$ MM) 1Q18 1Q17 1Q18/ Capex in IT 12.5 8.5 46.9% 10.3 21.7% Other Capex 0.3 0.2 75.0% 7.5-96.1% Right Assignment Agreeement / Exclusivity 13.6 9.4 44.1% 56.0-75.7% TOTAL 26.4 18.1 45.7% 73.7-64.2% Capital Structure (R$ MM) 1Q18 Var. 1Q18/ Current Debt 40.5 39.2 3.3% Long Term Debt (1) 619.8 613.3 1.1% TOTAL 660.3 652.5 1.2% Cash and cash equivalents (2) 527.5 517.7 1.9% TOTAL NET DEBT 132.8 134.8-1.4% (1) Includes acquisition payables. (2) Includes acquisition payables recognized as other payables. It does not include the investment retained as a guaranteed asset in the direct subsidiary Qualicorp Administradora de Benefícios S.A., and in the indirect subsidiarie Clube de Saúde Administradora de Benefícios Ltda., according to the 33rd normative instruction by the ANS, from October 5, 2009. 13

Cash Flow Cash Flow 1Q18 3Q17 2Q17 1Q17 Income adjusted by non-cash effects 260,110 225,286 293,744 266,345 269,465 Working Capital 67,827 (123,585) (30,340) (89,595) 38,523 Interest paid - (32,769) - (41,191) - Dividends received/paid - (9,440) (2,245) (6,242) (1,145) Income tax and social contribution paid (33,744) (47,321) (41,504) (33,962) (25,288) Cash Flow from Operating Activities 294,193 12,171 219,655 95,355 281,555 Capex (TI) (10,644) (13,024) (10,814) (7,160) (9,605) PP&E (429) (7,301) (650) (504) (370) New Sales Comissions (14,247) (16,378) (16,904) (18,787) (17,330) Intangible (M&A + Portfolio + Deals) (25,340) (315,617) (7,316) (374) (32,717) Cash Flow from Investment Activities (50,660) (352,320) (35,684) (26,825) (60,022) Cash Flow from Operating Activities (-) Capex 243,533 (340,149) 183,971 68,530 221,533 Cash Flow from Financing Activities (233,031) 4,852 (57,024) (27,517) - Other Investments 21,434 199,720 (124,783) 13,669 (138,760) Total Cash Flow 31,936 (135,577) 2,164 54,682 82,773 Cash Flow on the begining of the period 146,733 282,310 280,146 225,464 125,361 Cash Flow on the end of the period 178,669 146,733 282,310 280,146 225,464 14

Thank you! IR Contact Tel: +55 11 3191-3829 E-mail: ri@qualicorp.com.br